PMID: 2119513Jan 1, 1990Paper

Quantitative pharmaco-EEG study of nootropics

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica
T Kinoshita

Abstract

A treatment of geriatric disorders is one of the current major problems socially as well as medically. Thus nootropics have become one of the biggest topics in drug developments. Unfortunately, it is still very difficult to assess brain dysfunctions and therapeutic efficacies of these drugs objectively. Giurgea has proposed a new drug category, "nootropic", as those substances which possess an anti-dementia action, yet the general concept remains obscure. The present author expand the concept that those substances which improve the vigilance level to be included. The author has been engaged with computer assisted pharmaco-electroencephalography and research of nootropics for last several years. Based on the own experiences, the author presented the CNS effects of five different substances such as meclofenoxate, amantadine, piracetam, teniloxazine and WEB-1881, which were regarded as nootropics from various reasons. Single dose of each substances was administered in healthy young volunteers, and teniloxazine was given to geriatric patients. EEG changes induced by these substances in normal subjects were an increase of alpha activity, particularly in higher frequency range above 9.5 Hz, and an associated decrease of slow activity...Continue Reading

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.